| Total | T1 (< 92 pg/ml) | T2 (92–335 pg/ml) | T3 (≥ 336 pg/ml) | P value |
---|---|---|---|---|---|
Number | 7956 | 2653 | 2655 | 2648 | Â |
Clinical characteristics | Â | Â | Â | Â | Â |
 Age, year | 65.4 ± 10.5 | 60.8 ± 8.6 | 65.9 ± 9.7 | 69.6 ± 11.0 |  < 0.001 |
 Male, n (%) | 4986 (62.7) | 1885 (71.1) | 1547 (58.3) | 1554 (58.7) |  < 0.001 |
 BMI, kg/m2 | 25.9 ± 3.6 | 26.2 ± 3.4 | 26.0 ± 3.7 | 25.5 ± 3.7 |  < 0.001 |
 Heart rate, bpm | 71.4 ± 12.2 | 71.3 ± 10.6 | 69.6 ± 10.9 | 73.3 ± 14.5 |  < 0.001 |
 SBP, mmHg | 132.9 ± 18.1 | 130.1 ± 15.5 | 133.7 ± 17.5 | 135.1 ± 20.7 |  < 0.001 |
 DBP, mmHg | 75.6 ± 11.6 | 77.1 ± 11.1 | 75.3 ± 11.4 | 74.4 ± 12.0 |  < 0.001 |
Diabetes status, n (%) | Â | Â | Â | Â | Â |
 Normoglycemia | 1848 (23.2) | 687 (25.9) | 637 (24.0) | 524 (19.8) |  < 0.001 |
 Prediabetes | 2360 (29.7) | 822 (31.0) | 777 (29.3) | 761 (28.7) |  |
 Diabetes | 3748 (47.1) | 1144 (43.1) | 1241 (46.7) | 1363 (51.5) |  |
Previous hypertension, n (%) | 5736 (72.1) | 1786 (67.3) | 1955 (73.6) | 1995 (75.3) |  < 0.001 |
Previous dyslipidemia, n (%) | 3861 (48.5) | 1357 (51.1) | 1335 (50.3) | 1169 (44.1) |  < 0.001 |
Previous MI, n (%) | 630 (7.9) | 114 (4.3) | 201 (7.6) | 315 (11.9) |  < 0.001 |
Previous stroke, n (%) | 1462 (18.4) | 350 (13.2) | 501 (18.9) | 611 (23.1) |  < 0.001 |
Previous PCI, n (%) | 1200 (15.1) | 318 (12.0) | 429 (16.2) | 453 (17.1) |  < 0.001 |
Current smoker, n (%) | 2606 (32.8) | 997 (37.6) | 791 (29.8) | 818 (30.9) |  < 0.001 |
LVEF, % | 65.6 ± 6.8 | 67.6 ± 4.8 | 66.6 ± 5.9 | 62.5 ± 8.1 |  < 0.001 |
NSTE-ACS status, n (%) | Â | Â | Â | Â | Â |
 UA | 6183 (77.7) | 2532 (95.4) | 2271 (85.5) | 1380 (52.1) |  < 0.001 |
 NSTEMI | 1773 (22.3) | 121 (4.6) | 384 (14.5) | 1268 (47.9) |  |
Laboratory examinations | Â | Â | Â | Â | Â |
 FPG, mmol/L | 6.1 ± 2.2 | 6.0 ± 1.9 | 6.1 ± 2.1 | 6.3 ± 2.4 |  < 0.001 |
 HbA1c, % | 6.5 ± 1.4 | 6.4 ± 1.3 | 6.5 ± 1.4 | 6.6 ± 1.4 |  < 0.001 |
 Hemoglobin, g/l | 133.9 ± 17.9 | 140.1 ± 15.1 | 133.4 ± 16.2 | 128.2 ± 20.1 |  < 0.001 |
 eGFR, ml/min/1.73m2 | 112.7 ± 30.5 | 124.0 ± 27.0 | 113.7 ± 28.5 | 100.4 ± 31.2 |  < 0.001 |
 eGFR < 60 ml/min/1.73m2, n (%) | 324 (4.1) | 16 (0.6) | 65 (2.4) | 243 (9.2) |  < 0.001 |
 hs-CRP, mg/l | 1.7 (0.7, 5.3) | 1.1 (0.5, 2.8) | 1.4 (0.6, 3.9) | 3.4 (1.2, 12.3) |  < 0.001 |
 hs-CRP ≥ 3 mg/l, n (%) | 2696 (33.9) | 568 (21.4) | 785 (29.6) | 1343 (50.7) |  < 0.001 |
 Peak value of NT-proBNP, pg/ml | 165.0 (65.8, 527.5) | 46.9 (29.7, 65.8) | 165.0 (122.0, 227.0) | 983.5 (528.0, 2380.0) |  < 0.001 |
 Triglyceride, mmol/l | 1.36 (0.99, 1.93) | 1.46 (1.05, 2.04) | 1.37 (1.00, 1.95) | 1.28 (0.94, 1.81) |  < 0.001 |
 Total cholesterol, mmol/l | 4.23 ± 1.05 | 4.21 ± 1.03 | 4.23 ± 1.04 | 4.26 ± 1.09 | 0.320 |
 LDL-C, mmol/l | 2.39 ± 0.75 | 2.36 ± 0.72 | 2.37 ± 0.75 | 2.42 ± 0.78 | 0.007 |
 HDL-C, mmol/l | 1.09 ± 0.27 | 1.08 ± 0.25 | 1.10 ± 0.27 | 1.07 ± 0.27 |  < 0.001 |
In-hospital treatment, n (%) | Â | Â | Â | Â | Â |
 Aspirin | 7125 (89.6) | 2416 (91.1) | 2418 (91.1) | 2291 (86.5) |  < 0.001 |
 Clopidogrel/Ticagrelor | 4420 (55.6) | 1212 (45.7) | 1447 (54.5) | 1761 (66.5) |  < 0.001 |
 β-Blocker | 5240 (65.9) | 1648 (62.1) | 1705 (64.2) | 1887 (71.3) |  < 0.001 |
 ACEI/ARB | 4222 (53.1) | 1155 (43.5) | 1404 (52.9) | 1663 (62.8) |  < 0.001 |
 Statins | 7064 (88.8) | 2387 (90.0) | 2377 (89.5) | 2300 (86.9) |  < 0.001 |
 PCI | 3957 (49.7) | 1145 (43.2) | 1339 (50.4) | 1473 (55.6) |  < 0.001 |